Insulin resistance affects gene expression in endothelium [3]

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 2, 2008, Pages

  Consoli, Claudia ^a,b   Martelli, Eugenio ^c   D'Adamo, Monica ^a   Menghini, Rossella ^a   Arcelli, Diego ^d   Porzio, Ottavia ^a   Pandolfi, Assunta ^e   Pistolese, Giuseppe R ^c   Consoli, Agostino ^e   Lauro, Renato ^a   Ippoliti, Arnaldo ^c   Federici, Massimo ^a  

^a Department of Internal Medicine ^*  (Italy)

^b Clinica Santa Lucia   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^e UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; COLLAGEN TYPE 3; CYCLIN DEPENDENT KINASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE TRANSFERASE M3; HERMES ANTIGEN; INITIATION FACTOR 5A; INSULIN RECEPTOR SUBSTRATE 1; LYMPHOTOXIN BETA; PLACENTA PROTEIN 5; PROTEIN KINASE B; SULFATASE; THROMBOMODULIN; TUMOR NECROSIS FACTOR; UROKINASE; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY SURGERY; CORONARY ARTERY DISEASE; DNA MICROARRAY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; INSULIN RESISTANCE; LETTER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; UMBILICAL VEINS;

EID: 38549134086     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.152264     Document Type: Letter

References (12)

1. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113:1888-1904.
2. Federici M, Pandolfi A, De Filippis EA, Pellegrini G, Menghini R, Lauro D, Cardellini M, Romano M, Sesti G, Lauro R, Consoli A. G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells. Circulation. 2004;109:399-405.
3. Baroni MG, Arca M, Sentinelli F, Buzzetti R, Capici F, Lovari S, Vitale M, Romeo S, Di Mario U. The G972R variant of the insulin receptor substrate-1 (IRS-1) gene, body fat distribution and insulin-resistance. Diabetologia. 2001;44:367-372.
4. Baroni MG, D'Andrea MP, Montali A, Pannitteri G, Barilla F, Campagna F, Mazzei E, Lovari S, Seccareccia F, Campa PP, Ricci G, Pozzilli P, Urbinati G, Arca M. A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol. 1999;19:2975-2980.
5. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest. 1996;98:894-898.
6. Balduini A, d'Apolito M, Arcelli D, Conti V, Pecci A, Pietra D, Danova M, Benvenuto F, Perotti C, Zelante L, Volinia S, Balduini CL, Savoia A. Cord blood in vitro expanded CD41 cells: identification of novel components of megakaryocytopoiesis. J Thromb Haemost. 2006;4:848-860.
7. Penz S, Reininger AJ, Brandl R, Goyal P, Rabie T, Bernlochner I, Rother E, Goetz C, Engelmann B, Smethurst PA, Ouwehand WH, Farndale R, Nieswandt B, Siess W. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. FASEB J. 2005;19:898-909.
8. Crawley JT, Goulding DA, Ferreira V, Severs NJ, Lupu N. Expression and localization of tissue factor pathway inhibitor-2 in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol. 2002;22:218-224.
9. Blann AD, Seigneur M, Steiner M, Boisseau MR, McCollum CN. Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease. Eur J Clin Invest. 1997;27:916-921.
10. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol. 2001;21:1104-1117.
11. Berria R, Wang L, Richardson DK, Finlayson J, Belfort R Pratipanawatr T, De Filippis EA, Kashyap S, Mandarino LJ. Increased collagen content in insulin-resistant skeletal muscle. Am J Physiol Endocrinol Metab. 2006;290:E560-E565.
12. Herman MP, Sukhova GK, Kisiel W, Foster D, Kehry MR, Libby P, Schonbeck U. Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J Clin Invest. 2001;107:1117-1126.